poisar

Stock

Foghorn Therapeutics Inc. FHTX

$6.26-3.54%

Overview

FHTX market data

Price History

FHTX price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$1.18
Diluted earnings per share over the trailing twelve months.
Beta
2.99
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-175.8%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$3.27 – $6.95
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $385.4M · P/B 2,666.96 · P/S 10.49.

Company News

3 captured
Foghorn Therapeutics shares are trading higher after the company reported better-than-expected Q2 financial results.Benzinga · Aug 6, 2026, 5:13 PM
Foghorn Therapeutics Q2 EPS $(0.10) Beats $(0.23) Estimate, Sales $16.072M Beat $5.995M EstimateBenzinga · Aug 6, 2026, 11:41 AM
Step Pharma announces the appointment of Neil Gallagher as Non-Executive DirectorGlobenewswire Inc · Jul 1, 2026, 11:15 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock